Molecular Devices 美谷分子仪器（上海）有限公司
Molecular Devices provides life science instruments, AI-enabled software, and reagents for microplate assays, high-content imaging, colony picking, and 3D organoid workflows, serving pharmaceutical, biotech, and academic research customers globally as a Danaher Life Sciences subsidiary.
- Company typePrivate
- Founded2011
- HeadquartersShanghai, China
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
What Molecular Devices 美谷分子仪器（上海）有限公司 does
Molecular Devices is a life sciences instrumentation company that designs, manufactures, and sells integrated hardware and software platforms for drug discovery, cell biology, and clinical research. The core product portfolio comprises SpectraMax multi-mode microplate readers, ImageXpress high-content imaging and screening systems (including HCS.ai with AgileOptix technology), QPix and ClonePix automated microbial and mammalian colony picking systems, and DispenCell/CloneSelect Imager single-cell cloning and growth analysis instruments. Underlying software includes SoftMax Pro and SoftMax Pro GxP for plate reader acquisition and regulated environments, IN Carta for AI-powered image analysis with deep learning segmentation and the Phenoglyphs classification module, and MetaXpress for high-content image acquisition and analysis. CellXpress.ai extends the stack into AI-driven automated 3D cell culture with machine learning-assisted monitoring, feeding, imaging, and scheduling.
The company generates revenue through capital equipment sales (high-value instruments with long sales cycles targeting enterprise pharmaceutical and biotech customers), software licenses and subscriptions (IN Carta, MetaXpress, SoftMax Pro), recurring reagents, kits, and consumables, professional service and maintenance contracts, and a custom organoid expansion service that produces quality-controlled patient-derived organoids (PDOs) at scale via proprietary bioreactor and bioprocess technology acquired through the 2022 purchase of Cellesce. Go-to-market is direct enterprise field sales supported by inside sales, expert consultation, on-site/remote product demonstrations, webinars, and an RFQ/quote-request process; pricing is not publicly disclosed. Customer segments include pharmaceutical and biotechnology companies (primary), academic and research institutions (primary), cell line development and antibody discovery teams, and drug safety/toxicology departments. Molecular Devices is a wholly-owned subsidiary of Danaher Corporation (NYSE: DHR) operating under the Danaher Life Sciences platform, with regional headquarters in Shanghai, China and global operations spanning North America, Europe, and Asia-Pacific.
Molecular Devices 美谷分子仪器（上海）有限公司 firmographics
Firmographics- Name
- Molecular Devices 美谷分子仪器（上海）有限公司
- Legal name
- Molecular Devices 美谷分子仪器（上海）有限公司
- Website
- https://moleculardevices.com.cn
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Short description
- Molecular Devices provides life science instruments, AI-enabled software, and reagents for microplate assays, high-content imaging, colony picking, and 3D organoid workflows, serving pharmaceutical, biotech, and academic research customers globally as a Danaher Life Sciences subsidiary.
- Ownership category
- akta.pro rank
Molecular Devices 美谷分子仪器（上海）有限公司 industry classification
Industry- Product category
- Life Science Instrumentation
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)
- akta.pro secondary industries
- AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO), In Vitro Model Systems & Organoid Platforms (iPSC/organoids, microphysiological systems) (HLAAAIAJ)
Keywords
Where Molecular Devices 美谷分子仪器（上海）有限公司 is headquartered
LocationHeadquarters
- HQ city
- Shanghai
- HQ country
- China
- HQ region
- Asia
Offices1 record
Markets served
Molecular Devices 美谷分子仪器（上海）有限公司 business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Scientific Instrumentation Hardware Sales: Sale of high-value capital equipment including microplate readers, high-content imaging systems, automated colony pickers, and cell culture systems. These are typically one-time capital purchases with long sales cycles targeting enterprise pharmaceutical and biotech customers.
- Software Licenses and Subscriptions: Software products including SoftMax Pro, IN Carta, MetaXpress, and CellReporterXpress offered as licensed software with associated maintenance and support contracts.
- Reagents, Kits, and Consumables: Supporting reagents, assay kits, culture media (CloneMedia), and consumables for use with instrumentation platforms, providing recurring revenue from consumable sales.
- Service, Support, and Maintenance: Field service, installation, IQ/OQ/PM services, technical support, and application support services for instrument operation in customer laboratories.
- Custom Organoid Services: Custom organoid expansion services providing large-scale, quality-controlled organoid production using proprietary technology for drug discovery screening applications.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom enterprise pricing via RFQ |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Molecular Devices 美谷分子仪器（上海）有限公司 product offering
Product offeringCore offering
Molecular Devices develops and sells life science instrumentation and software for drug discovery and cellular biology research. Its core offerings include SpectraMax microplate readers, ImageXpress high-content imaging systems, QPix/ClonePix automated colony pickers, AI-powered image analysis software (IN Carta, MetaXpress), and 3D Ready organoid expansion services for pharmaceutical, biotech, and academic research customers.
Product overview
Molecular Devices is a life sciences instrumentation company offering an integrated portfolio of products for drug discovery and cellular biology research. The core platform consists of SpectraMax microplate readers (enzyme label detectors) for absorbance/fluorescence/luminescence measurements, ImageXpress high-content imaging and screening systems for cellular analysis, and QPix/ClonePix automated colony picking systems for clone screening. Add-on modules include SoftMax Pro GxP software for regulated environments, IN Carta AI-powered image analysis software, and CellXpress.ai automated cell culture systems. Services include 3D Ready organoid expansion for scalable patient-derived organoid production. The portfolio supports complex biology workflows including 3D cell models, organoids, CRISPR-based gene editing, and high-throughput screening applications.
Differentiator
Problem solved
Functional benefit
Brands
- Cellesce: Patient-derived organoid (PDO) developer and manufacturer acquired by Molecular Devices in 2022
- SpectraMax
- ImageXpress
- QPix
- ClonePix
- CellXpress.ai
- IN Carta
- MetaXpress
- Organoid Innovation Center
Products and services
- SpectraMax iD3s/iD5e Multi-Mode Microplate Readers (SpectraMax iD3s/iD5e 多功能微孔板读板机) Next-generation multi-mode microplate readers for detecting absorbances, fluorescence, luminescence, and other assay formats in molecular biology research, integrating with SoftMax Pro software.
- ImageXpress HCS.ai High-Content Screening System (ImageXpress HCS.ai 高内涵筛选系统) AI-powered high-content screening system with AgileOptix technology combining solid-state light engine, water immersion objectives, scientific CMOS sensor, and proprietary dual-spinning disk technology for 3D phenotypic analysis.
- ImageXpress Pico Automated Cell Imaging System (ImageXpress Pico 自动化细胞成像分析系统) Automated cell imaging and analysis system for fluorescence and brightfield applications enabling high-content analysis of cell-based assays with integrated software for image acquisition and data analysis.
- QPix FLEX Microbial Colony Picking System (QPix FLEX 微生物克隆拣选系统) Space-saving automated microbial colony picking system with high-resolution color camera optimized for hypoxic incubation environments, precise picking, color imaging for morphology analysis, UV contamination removal, and 2D barcode tracking.
- QPix 400 Series Microbial Colony Picking Systems (QPix 400 系列微生物克隆筛选系统) Automated high-throughput microbial colony picking systems including QPix 420, QPix 450/460, QPix XE, QPix LH, QPix Select HT, and QPix Select HT-LH models with automated picking, plating, replication, re-arraying, and fluorescent screening capabilities, achieving up to 3,000 clones per hour.
- ClonePix 2 Mammalian Colony Picking System (ClonePix 2 哺乳动物细胞克隆筛选系统) Fully automated mammalian cell colony picking system for antibody development and cell line development. Screens hybridoma, CHO, stem cells based on protein productivity, antigen specificity, with optional Day 0 monoclonality verification.
- IN Carta Image Analysis Software (IN Carta 图像分析软件) AI-powered image analysis software with deep learning segmentation and machine learning classification for high-content screening, including 3D spheroid and organoid analysis with Phenoglyphs module.
- MetaXpress High-Content Image Acquisition and Analysis Software (MetaXpress 高内涵图像获取和分析软件) Image acquisition and analysis software for ImageXpress high-content imaging systems with intelligent QuickID targeted acquisition capabilities for efficient imaging workflows.
- SoftMax Pro GxP Software (SoftMax Pro GxP 软件) Data acquisition and analysis software for microplate readers with GxP compliance features including audit trails, electronic signatures, and data integrity controls for regulated GMP/GLP laboratories.
- CellXpress.ai Automated Cell Culture System (CellXpress.ai 自动化细胞培养系统) AI-driven automated cell culture system that automates processes, improves workflows, and enables more reliable and reproducible assays through machine learning-assisted monitoring, feeding, imaging, and scheduling.
- 3D Ready Organoid Expansion Service (3D Ready 类器官扩增服务) Large-scale organoid expansion service using proprietary bioreactor and bioprocess technology to produce quality-controlled patient-derived organoids (PDOs) for high-throughput screening, delivering 4-6 million organoids per batch.
- SpectraMax Mini Microplate Reader (SpectraMax Mini 微孔板读板机) Compact microplate reader designed for cost-effective absorbance measurements in basic research applications, available in bundle with MultiWash for plate washing capabilities.
- GxP Compliance Solutions (GxP 合规性解决方案) Complete GxP compliance solutions combining SpectraMax microplate readers, SoftMax Pro GxP software, SpectraTest validation plates, and IQ/OQ/PM services for laboratories operating under GMP and GLP regulations.
- ELISA Workcell (ELISA 工作单元) Fully integrated, automated ELISA workflow solutions for cell and biochemical assays that support unattended operation and improve detection throughput, effectiveness, efficiency, and reproducibility.
- DispenCell Single-Cell Dispenser (DispenCell 单细胞分配器) Single-cell dispensing system for monoclonality verification providing gentle cell handling to maintain viability, instant and traceable clonality proof, compact design, and disposable tips to prevent cross-contamination.
- CloneSelect Imager FL Cell Growth Analysis System (CloneSelect Imager 细胞生长分析系统 FL) Cell growth analysis and imaging system for mammalian cells with fluorescence capabilities providing monoclonality verification, automatic confluence analysis, and 96-well plate imaging in two minutes.
Quantifiable outcome
- Up to 10x faster organoid production (4-6 million organoids per batch vs. conventional manual methods)
- +3 more outcomes
Companies that use Molecular Devices 美谷分子仪器（上海）有限公司
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
Molecular Devices 美谷分子仪器（上海）有限公司 technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature10 records
Molecular Devices 美谷分子仪器（上海）有限公司 partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- CellescecoreMolecular Devices acquired Ellesce, a developer and manufacturer of patient-derived organoids (PDOs), in 2022. Ellesce's large-scale manufacturing uses proprietary bioreactor and bioprocess technology. The acquisition complements Molecular Devices' existing portfolio, enabling the company to provide customers with both off-the-shelf and customized manufactured organoids at scale along with workflow solutions and turnkey offerings, from screening through imaging and analysis.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
Molecular Devices 美谷分子仪器（上海）有限公司 competitors and assessment
Company assessmentBroad incumbents
- Bruker: Bruker is a broad incumbent in scientific instruments with growing presence in cellular analysis and high-content imaging. Its acquisition of PhenomeX (spatial biology) and investments in cell biology place it as an adjacent competitor for advanced imaging budgets.
- Agilent Technologies: Agilent is a broad incumbent in analytical instruments for life sciences, including cell analysis and genomics-adjacent workflows. While less directly competitive in microplate readers, it competes for the same pharma/biopharma analytical instrument budgets.
- Sartorius: Sartorius is a broad incumbent in bioprocessing and cell line development, with growing investments in cell biology and organoid workflows. Its cell line development and bioreactor capabilities directly overlap with MD's ClonePix and 3D Ready organoid offerings.
- Revvity (formerly PerkinElmer): Revvity is a broad incumbent in life sciences and diagnostics, with overlapping high-content imaging, microplate reader, and cell analysis offerings. Following the PerkinElmer split, Revvity sharpened focus on life sciences tools comparable to MD's portfolio.
- Thermo Fisher Scientific: Thermo Fisher is a broad incumbent spanning instruments, reagents, and consumables across drug discovery. It competes with MD through its laboratory instruments division and increasingly in organoid/cell biology through acquisitions like Patheon and Olink adjacency.
- Beckman Coulter Life Sciences: Beckman Coulter Life Sciences (Danaher sister company) competes in flow cytometry, cell sorting, and laboratory automation. Its automated cell analysis capabilities overlap with MD's ClonePix and QPix colony screening and broader cell biology workflow offerings.
Direct peers
- Tecan: Tecan is a direct peer in microplate readers, liquid handling, and lab automation. It competes head-to-head with Molecular Devices' SpectraMax readers and automated workflow solutions across pharma and academic research customers.
- Bio-Rad Laboratories: Bio-Rad is a direct peer in life science research instruments, including microplate readers and cell biology workflow tools. Both serve pharma/biotech R&D and academic core facilities with overlapping product portfolios in protein and cell-based assays.
- Hamilton Company: Hamilton is a direct peer in laboratory automation, liquid handling, and high-throughput screening workflows. It competes with MD for automated cell culture and integrated pharma/biotech workflow contracts.
- Yokogawa Electric: Yokogawa's CellVoyager high-content imaging systems directly compete with Molecular Devices' ImageXpress HCS.ai. Both target pharma HCS and 3D biology applications with comparable spinning-disk confocal imaging technology.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Molecular Devices 美谷分子仪器（上海）有限公司 social profiles
Digital presenceMolecular Devices 美谷分子仪器（上海）有限公司 compliance and trust
Trust signalCompliance4 records
Molecular Devices 美谷分子仪器（上海）有限公司 financial estimates
Financial estimateRevenue estimate
Valuation estimate
Molecular Devices 美谷分子仪器（上海）有限公司 leadership team
Management profileNumber of profiles
Profiles9 records
Molecular Devices 美谷分子仪器（上海）有限公司 subsidiaries and ownership
Company hierarchySubsidiaries1 record
Molecular Devices 美谷分子仪器（上海）有限公司 funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Molecular Devices 美谷分子仪器（上海）有限公司 M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Molecular Devices 美谷分子仪器（上海）有限公司
What does Molecular Devices 美谷分子仪器（上海）有限公司 do?
Molecular Devices develops and sells life science instrumentation and software for drug discovery and cellular biology research. Its core offerings include SpectraMax microplate readers, ImageXpress high-content imaging systems, QPix/ClonePix automated colony pickers, AI-powered image analysis software (IN Carta, MetaXpress), and 3D Ready organoid expansion services for pharmaceutical, biotech, and academic research customers.
Is Molecular Devices 美谷分子仪器（上海）有限公司 a public or private company?
Molecular Devices 美谷分子仪器（上海）有限公司 is a private company. It is classified as corporate owned and is currently operating.
When was Molecular Devices 美谷分子仪器（上海）有限公司 founded?
Molecular Devices 美谷分子仪器（上海）有限公司 was founded in 2011.
Where is Molecular Devices 美谷分子仪器（上海）有限公司 based?
Molecular Devices 美谷分子仪器（上海）有限公司 is headquartered in Shanghai, China, in the Asia region.
How does Molecular Devices 美谷分子仪器（上海）有限公司 make money?
Five revenue lines are on record. Scientific Instrumentation Hardware Sales are the primary driver. The others are software Licenses and Subscriptions, reagents, Kits, and Consumables, service, Support, and Maintenance and custom Organoid Services.
Who are Molecular Devices 美谷分子仪器（上海）有限公司's main competitors?
Broad incumbents on record are Bruker, Agilent Technologies, Sartorius, Revvity (formerly PerkinElmer), Thermo Fisher Scientific and Beckman Coulter Life Sciences. Direct peers are Tecan, Bio-Rad Laboratories, Hamilton Company and Yokogawa Electric.
Does Molecular Devices 美谷分子仪器（上海）有限公司 have an API?
No public API is recorded for Molecular Devices 美谷分子仪器（上海）有限公司.
What industry is Molecular Devices 美谷分子仪器（上海）有限公司 in?
Molecular Devices 美谷分子仪器（上海）有限公司's product category is Life Science Instrumentation. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments, with a secondary code of HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization. Its NAICS code is 334516 and its SIC code is 3826.